Subjects were cautioned that the study (1) was not a treatment, (2) was not intended to improve schizophrenia symptoms, (3) carried the possible risk of symptoms worsening, relapse, and hospitalization, and (4) was not a sanction to use alcohol. Subjects were required to pass a questionnaire about the study risks and benefits. Collaterals were involved in the consent process, inclusion was contingent on the clinician's approval, and an ombudsperson (clinician) was appointed to serve subjects.
Subjects were cautioned that the study (1) was not a treatment, (2) was not intended to improve schizophrenia symptoms, (3) carried the possible risk of symptoms worsening, relapse, and hospitalization, and (4) was not a sanction to use alcohol. Subjects were required to pass a questionnaire about the study risks and benefits. Collaterals were involved in the consent process, inclusion was contingent on the clinician's approval, and an ombudsperson (clinician) was appointed to serve subjects.
การแปล กรุณารอสักครู่..
